Soleno Therapeutics, Inc. Gains 28.57%
Tue, Dec 24, 2019 at 05:30 PM
Soleno Therapeutics, Inc. (SLNO:NASDAQ) shot up at $2.79, a gain of 28.6%. On Mon 23 Dec 19, SLNO:NASDAQ hit a New 2-Week High of $2.17. From Tue 03 Dec 19, the stock recorded 64.29% Up Days and 53.33% Green Days
The share price of the company has been moving sideways in recent weeks.
About Soleno Therapeutics, Inc. (SLNO:NASDAQ)
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases.
Top 10 Gainers:
- Microbot Medical Inc. (MBOT:NASDAQ), 61.03%
- Proteostasis Therapeutics, Inc. (PTI:NASDAQ), 51.01%
- CLPS Incorporation (CLPS:NASDAQ), 46.12%
- Lineage Cell Therapeutics, Inc. (LCTX:NYSEMKT), 34.52%
- TMSR Holding Company Limited (TMSR:NASDAQ), 33.33%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%
- Soleno Therapeutics, Inc. (SLNO:NASDAQ), 28.57%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 26.74%
- Hi-Crush Inc. (HCR:NYSE), 26.25%
- Applied Genetic Technologies Corporation (AGTC:NASDAQ), 23.98%